Clover Biopharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,686	3,037	313	804	3,348	15,727
Market Cap Growth	735.92%	871.54%	-61.11%	-75.99%	-78.71%	-
Enterprise Value	3,380	2,618	44	-89	785	16,969
Last Close Price	2.84	2.34	0.24	0.62	2.59	13.58
Forward PE	-	0.71	0.71	0.78	5.87	5.49
PS Ratio	945.14	778.62	7.65	18.58	-	-
PB Ratio	-1.84	-1.52	-0.18	-0.99	-4.43	10.51
P/TBV Ratio	-	-	-	-	-	10.63
EV/Sales Ratio	-	671.11	1.08	-	-	-
Debt / Equity Ratio	-0.01	-0.01	-0.05	-0.46	-0.53	0.06
Net Debt / Equity Ratio	0.15	0.15	0.20	0.57	1.90	-2.29
Net Debt / EBITDA Ratio	1.20	1.20	0.35	0.16	0.54	1.25
Net Debt / FCF Ratio	-	-	1.13	0.57	0.72	2.86
Asset Turnover	0.01	0.01	0.03	0.01	-	-
Inventory Turnover	0.07	0.07	2.01	1.11	0.30	0.16
Quick Ratio	0.16	0.16	0.25	0.36	0.57	1.33
Current Ratio	0.19	0.19	0.35	0.83	1.55	2.36
Return on Equity (ROE)	-	-	-	-	-889.96%	-5089.78%
Return on Assets (ROA)	-25.46%	-25.46%	-40.96%	-47.84%	-29.88%	-42.83%
Return on Capital Employed (ROCE)	20.00%	20.00%	87.20%	1481.60%	-128.70%	-70.00%
Earnings Yield	-6.19%	-7.51%	-307.56%	-18.99%	-82.79%	-46.96%
FCF Yield	-	-	-98.60%	-100.73%	-59.70%	-7.63%
Buyback Yield / Dilution	-2.25%	-2.25%	-0.82%	-12.83%	4.84%	-52.85%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.